Glaukos Corporation announced that the US Centers for Medicare and Medicaid Services (CMS) has assigned a permanent ...
Gabriel discusses a robotic femtosecond laser platform for LASIK, focusing on flap accuracy, stromal bed precision, and the ...
The management of dry eye disease may benefit from earlier intervention, according to data presented by Eric D. Donnenfeld, ...
On March 9, 2026, SpyGlass Pharma announced positive 12-month results from its phase 1/2 trial of the Bimatoprost Drug ...
Uncorrected acuity at 36 months showed continuous range: monocular 20/20 distance and intermediate, 20/27 near; binocular ...
For cataract surgeons, the conversation around phacoemulsification is increasingly shifting from ultrasound power to fluidics ...
New 52-week analyses from the phase 3 SOL-1 trial suggest that the investigational intravitreal therapy AXPAXLI (OTX-TKI) may ...
The FDA’s decision to extend the labeled duration of faricimab use in RVO beyond 6 months primarily reflects accumulated ...
As expectations for refractive cataract surgery continue to rise, preoperative ocular surface optimization remains essential ...
Evidence gaps include limited topline safety granularity, unknown long-term follow-up and retreatment rates, and lack of ...
Tran, MD, compared refractive accuracy, cylinder correction, and postoperative adjustment rates between femtosecond ...
Unmet need persists for globe-sparing retinoblastoma therapy that does not depend on intra-arterial chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results